Lymphadenopathy epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Kiran Singh (talk | contribs) |
No edit summary |
||
Line 9: | Line 9: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:primary care]] | [[Category:primary care]] | ||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
Line 14: | Line 15: | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Physical examination]] | [[Category:Physical examination]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 17:35, 24 August 2015
Lymphadenopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lymphadenopathy epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Lymphadenopathy epidemiology and demographics |
Risk calculators and risk factors for Lymphadenopathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
The estimated incidence of lymphadenopathy in children in the United States ranges from 35%- 45%. It is more common in the pediatric population. Race and gender have no predilection in lymphadenopathy incidence.